BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/22/2022 9:25:37 AM | Browse: 854 | Download: 2009
Publication Name World Journal of Hepatology
Manuscript ID 64923
Country Spain
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Methodology
Manuscript Type Review
Article Title Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
Manuscript Source Invited Manuscript
All Author List Maria Martin-Grau, Vannina G Marrachelli and Daniel Monleon
ORCID
Author(s) ORCID Number
Maria Martin-Grau http://orcid.org/0000-0002-8781-5952
Vannina G Marrachelli http://orcid.org/0000-0002-4097-3312
Daniel Monleon http://orcid.org/0000-0002-4803-1573
Funding Agency and Grant Number
Corresponding Author Daniel Monleon, PhD, Professor, Department of Pathology, University of Valencia, Avda Blasco Ibañez 15, Valencia 46010, Spain. daniel.monleon@uv.es
Key Words Non-alcoholic fatty liver disease; Liver disease; Rodent models; Metabolic profiling; Metabolomics; Biomarkers
Core Tip Non-alcoholic fatty liver disease (NAFLD) is a spectrum of different diseases that starts with asymptomatic steatosis, continues with steatohepatitis, and can progress to fibrosis. Current knowledge suggests that NAFLD initiates and progresses through most of nine hallmarks. Animal models remain crucial for understanding the disease and for developing tools based on biological knowledge. Metabolomics seems a valid tool for studying metabolic pathways and organ crosstalk in NAFLD. In this review, we provide a brief introduction to NAFLD hallmarks, the five groups of animal models available for studying NAFLD and the potential role of metabolomics in the study of experimental NAFLD.
Publish Date 2022-02-22 09:25
Citation Martin-Grau M, Marrachelli VG, Monleon D. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn? World J Hepatol 2022; 14(2): 304-318
URL https://www.wjgnet.com/1948-5182/full/v14/i2/304.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i2.304
Full Article (PDF) WJH-14-304.pdf
Full Article (Word) WJH-14-304.docx